HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lanying Du Selected Research

Poisoning

1/2018Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application.
10/2011Complement inhibition alleviates paraquat-induced acute lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lanying Du Research Topics

Disease

58Infections
01/2023 - 08/2006
20COVID-19
03/2024 - 01/2020
13Severe Acute Respiratory Syndrome
10/2021 - 08/2006
12Virus Diseases (Viral Diseases)
11/2021 - 01/2005
11Human Influenza (Influenza)
02/2015 - 09/2008
8Coronavirus Infections
01/2020 - 01/2015
6Zika Virus Infection
11/2021 - 01/2017
6Influenza in Birds (Avian Flu)
01/2015 - 07/2010
4Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 08/2015
3Acute Lung Injury
04/2018 - 10/2011
3Lung Injury
01/2018 - 01/2014
2Neoplasms (Cancer)
11/2022 - 01/2017
2Poisoning
01/2018 - 10/2011
2Acquired Immunodeficiency Syndrome (AIDS)
06/2017 - 08/2015
1Weight Loss (Weight Reduction)
10/2023
1Respiratory Insufficiency (Respiratory Failure)
04/2018
1Cytokine Release Syndrome
01/2018
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2018
1Body Weight (Weight, Body)
12/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Diarrhea
11/2016
1Emerging Communicable Diseases (Emerging Infectious Diseases)
03/2016
1Respiratory Syncytial Virus Infections
02/2015
1Viral Pneumonia
02/2015
1Hepatocellular Carcinoma (Hepatoma)
06/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
04/2014
1Intestinal Volvulus (Volvulus)
01/2012
1Hemorrhagic Fever with Renal Syndrome (HFRS)
09/2008

Drug/Important Bio-Agent (IBA)

50VaccinesIBA
03/2024 - 09/2006
36Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2005
20Neutralizing AntibodiesIBA
01/2022 - 09/2006
12AntibodiesIBA
11/2023 - 01/2013
10Subunit VaccinesIBA
01/2019 - 01/2008
9Antiviral Agents (Antivirals)IBA
01/2022 - 07/2010
7Recombinant ProteinsIBA
11/2020 - 09/2008
6Monoclonal AntibodiesIBA
10/2021 - 03/2010
6EpitopesIBA
01/2019 - 03/2008
5Peptides (Polypeptides)IBA
04/2020 - 03/2008
4Complement System Proteins (Complement)IBA
04/2018 - 10/2011
4Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2017 - 01/2013
3Broadly Neutralizing AntibodiesIBA
10/2023 - 01/2017
3COVID-19 VaccinesIBA
10/2023 - 01/2021
3HIV Protease InhibitorsIBA
11/2022 - 08/2015
3Nelfinavir (Viracept)FDA Link
11/2022 - 08/2015
3Immunoglobulin G (IgG)IBA
01/2018 - 08/2013
2mRNA VaccinesIBA
01/2023 - 10/2022
2Messenger RNA (mRNA)IBA
10/2022 - 06/2014
2GossypolIBA
01/2022 - 11/2019
2SARS-CoV-2 spike proteinIBA
10/2021 - 04/2020
2Angiotensin-Converting Enzyme 2IBA
01/2021 - 07/2020
2Immune Sera (Antisera)IBA
01/2020 - 08/2013
2CytokinesIBA
04/2018 - 01/2014
2ParaquatIBA
01/2018 - 10/2011
2Hemagglutinins (Hemagglutinin)IBA
12/2017 - 06/2013
2InterferonsIBA
12/2015 - 01/2014
2HIV Fusion InhibitorsIBA
08/2015 - 08/2013
2Human Serum AlbuminFDA LinkGeneric
02/2015 - 08/2013
2AntigensIBA
06/2014 - 09/2008
2Influenza Vaccines (Influenza Vaccine)FDA Link
01/2011 - 07/2010
2Recombinant Fusion ProteinsIBA
01/2011 - 10/2010
1Lipid NanoparticlesIBA
01/2022
1Single-Domain AntibodiesIBA
01/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2021
1EnzymesIBA
10/2021
1NanovaccinesIBA
01/2021
1SolutionsIBA
11/2020
1Protein SIBA
07/2020
1LipopeptidesIBA
04/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Fc Receptors (Fc Receptor)IBA
01/2020
1Polysaccharides (Glycans)IBA
01/2019
1ChemokinesIBA
04/2018
1vilobelimabIBA
01/2018
14Dm2mIBA
06/2017
1Metformin (Glucophage)FDA LinkGeneric
01/2017
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2017
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
11/2016
1MF59 oil emulsionIBA
03/2016
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
12/2015
1Cadherins (E-Cadherin)IBA
10/2015
1Enfuvirtide (Fuzeon)FDA Link
08/2015
1PalivizumabFDA Link
02/2015
1Maleic Anhydrides (Maleic Anhydride)IBA
02/2015
1MicroRNAs (MicroRNA)IBA
06/2014
1Hepatocyte Nuclear FactorsIBA
06/2014
1ADS J1IBA
05/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1Monocyte Chemoattractant ProteinsIBA
01/2014
1avian influenza A virus hemagglutininIBA
10/2013
13-hydroxyphthalic anhydrideIBA
08/2013
1HA 7IBA
02/2013
1Viral HemagglutininsIBA
06/2011
13- fluoro- N- (2- (1- piperidinyl)ethyl)- 5- (trifluoromethyl)benzamideIBA
06/2011
1piperidineIBA
06/2011
1Protein Subunit VaccinesIBA
07/2010
1OvalbuminIBA
09/2008

Therapy/Procedure

20Therapeutics
11/2023 - 04/2010
1Intranasal Administration
02/2015